Glucocorticoids discontinuation in systemic lupus erythematosus: a single-centre study
Most SLE patients have difficulty maintaining prolonged stabilization after discontinuing GC and regain remission within a year of relapse. Before discontinuing GC, risk factors associated with recurrence of SLE need to be assessed.
Authors
- Renju Xu
- Hongmei Deng (ORCID: https://orcid.org/0000-0002-2438-2088)
- Guangcai Chen (ORCID: https://orcid.org/0000-0001-6564-1798)
- Xuebing Feng (ORCID: https://orcid.org/0000-0002-9837-9690)
- D Chen
- Yaqi Zhang (ORCID: https://orcid.org/0000-0002-8281-3122)
- Yi Wang (ORCID: https://orcid.org/0000-0002-7094-9794)
- Yujiao Wang (ORCID: https://orcid.org/0009-0004-9024-3125)
- Ziyi Jin
- Mian Liu (ORCID: https://orcid.org/0009-0001-6836-0016)
Institutions
- Nanjing University of Chinese Medicine (CN)
- China Pharmaceutical University (CN)
- Peking Union Medical College Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Chinese Academy of Medical Sciences Dermatology Hospital (CN)
Publication Details
- Journal
- Rheumatology Advances in Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/rap/rkaf036
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 3.34